![]() |
|
|
Vol. 282, Issue 3, 1326-1330, 1997
-Adrenoceptor-Mediated Prejunctional Effects of
Chloroethylclonidine in the Canine Saphenous Vein1
Institute of Pharmacology and Therapeutics, Faculty of Medicine,
4200-Porto, Portugal
The present study was undertaken to look for the effect of
chloroethylclonidine (CEC) on prejunctional alpha-2
autoreceptors of the canine saphenous vein. The effect was tested on
tritium overflow evoked by electrical stimulation from tissues
preloaded with 0.2 µM 3H-norepinephrine. Yohimbine
(3-300 nM) and CEC (1-125 µM) increased and UK-14,304 reduced the
overflow of tritium evoked by 300 pulses (1 Hz). The maximal increase
of tritium overflow caused by yohimbine was much higher than that
caused by CEC: 3.82 and 1.74 times, respectively. CEC (5 µM)
abolished both the inhibition caused by UK-14,304 and the enhancement
of tritium overflow caused by yohimbine. However, when CEC was added
after yohimbine, it reduced the electrically evoked overflow of
tritium, the maximal effect being a reduction of tritium overflow by
35%. Prazosin (1-100 nM) did not change either the inhibitory effect
of UK-14,304 or the facilitatory effect of CEC. These results suggest
that CEC acts on two different subtypes of prejunctional
alpha-2 autoreceptors; on one of them it acts as an
antagonist and increases the electrically evoked overflow of tritium
(and inhibits both the effect of UK-14,304 and yohimbine); on the other
it acts as an agonist and reduces the electrically evoked overflow of
tritium. Alternatively, one can admit that CEC is able to inhibit
alpha-2 autoreceptors, which causes an increase of the
transmitter release, and to activate a nonadrenergic inhibitory
receptor thus causing a reduction of the transmitter release.
This article has been cited by other articles:
![]() |
S. Boehm and H. Kubista Fine Tuning of Sympathetic Transmitter Release via Ionotropic and Metabotropic Presynaptic Receptors Pharmacol. Rev., March 1, 2002; 54(1): 43 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marjamaki, H. Frang, M. Pihlavisto, A.-M. Hoffren, T. Salminen, M. S. Johnson, J. Kallio, J. A. Javitch, and M. Scheinin Chloroethylclonidine and 2-Aminoethyl Methanethiosulfonate Recognize Two Different Conformations of the Human alpha 2A-Adrenergic Receptor J. Biol. Chem., July 30, 1999; 274(31): 21867 - 21872. [Abstract] [Full Text] [PDF] |
||||